CAPTRUST Financial Advisors
NBP

CAPTRUST Financial Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

CAPTRUST Financial Advisors’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,675
Closed -$158K – 3449
2020
Q3 		$158K Buy
+3,675
New +$121K ﹤0.01% 1140

Other funds holding NBP

CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
WA
WFM Asia Road Town, Tortola, British Virgin Islands $632M AUM 14.51% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

CAPTRUST Financial Advisors's NBP Position: Q4 2020 in Review

CAPTRUST Financial Advisors sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2020, closing a stake of 3,675 shares — an estimated $158K sold.

CAPTRUST Financial Advisors first reported a position in NBP in Q3 2020 and held it in 1 quarter. The position peaked at $158K in Q3 2020. 65 funds tracked by Wall St. Rank hold NBP as of Q4 2020.

  • CAPTRUST Financial Advisors reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 3,675 NovaBridge Biosciences American Depositary Shares shares in Q4 2020, an estimated $158K.
  • CAPTRUST Financial Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and held it in 1 quarter.
  • CAPTRUST Financial Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $158K in Q3 2020.
  • 65 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2020.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.